Femara cuts cancer recurrence even if started late (Reuters, 10 March 2008)

Wellcome Trust Training Fellowships for Clinicians in Basic Sciences

Merck obesity drug falls short in trial - analyst (The Guardian, 10 March 2008)

12 Mar 2008

Merck & Co's experimental obesity drug taranabant has not shown impressive effectiveness in a late-stage trial and its side effects were worse than expected.

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read